Inventor · disambiguated record
Stephen W. Burgess
Also filed as: BURGESS STEPHEN W
17 granted patents·6 pending applications·110 citations·filing 1997–2019
92Inventor score
Files withAVANTI POLAR LIPIDS INC9BIOMOLECULAR PRODUCTS INC4AVANTI POLAR LIPIDS LLC2LOS ANGELES CHILDRENS HOSPITAL2SIGNPATH PHARMA INC2
Top patents by PatentIndex Score
23 records- 0192US10258691B2Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathiesSIGNPATH PHARMA INC·Filed 2015·Granted Apr 16, 2019·16 cites·10 claims
- 0289US9241988B2Disaccharide synthetic lipid compounds and uses thereofAVANTI POLAR LIPIDS INC·Filed 2013·Granted Jan 26, 2016·19 cites·12 claims
- 0381US9872908B2Oral composition for delivery of drugs and other substancesAVANTI POLAR LIPIDS INC·Filed 2015·Granted Jan 23, 2018·3 cites·15 claims
- 0478US9518078B2Disaccharide synthetic lipid compounds and uses thereofAVANTI POLAR LIPIDS INC·Filed 2013·Granted Dec 13, 2016·5 cites·13 claims
- 0577US7785621B2Oral compositions of fenretinide having increased bioavailability and methods of using the sameLOS ANGELES CHILDRENS HOSPITAL·Filed 2004·Granted Aug 31, 2010·12 cites·18 claims
- 0675US5948878ACationic polymers for nucleic acid transfection and bioactive agent deliveryFiled 1997·Granted Sep 7, 1999·47 cites·16 claims
- 0774US10463738B2Oral composition for delivery of drugs and other substancesAVANTI POLAR LIPIDS INC·Filed 2017·Granted Nov 5, 2019·1 cites·20 claims
- 0874US10143744B2Disaccharide synthetic lipid compounds and uses thereofAVANTI POLAR LIPIDS INC·Filed 2016·Granted Dec 4, 2018·2 cites·20 claims
- 0971US8222233B2Modifications of solid 3-sn-phosphoglyceridesYESAIR DAVID W·Filed 2011·Granted Jul 17, 2012·1 cites·8 claims
- 1071US7780978B2Oral pharmaceutical compositions and methods of using the sameLOS ANGELES CHILDRENS HOSPITAL·Filed 2005·Granted Aug 24, 2010·1 cites·19 claims
- 1169US11510985B2Oral composition for delivery of drugs and other substancesAVANTI POLAR LIPIDS LLC·Filed 2019·Granted Nov 29, 2022·0 cites·16 claims
- 1269US7407779B2Modification of solid 3-sn-phosphoglyceridesBIOMOLECULAR PRODUCTS INC·Filed 2002·Granted Aug 5, 2008·3 cites·23 claims
- 1365US7947306B2Modifications of solid 3-sn-phosphoglyceridesBIOMOLECULAR PRODUCTS INC·Filed 2008·Granted May 24, 2011·0 cites·12 claims
- 1460US9403760B2CompoundsAVANTI POLAR LIPIDS INC·Filed 2013·Granted Aug 2, 2016·0 cites·16 claims
- 1559US2014011891A1MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDESBIOMOLECULAR PRODUCTS INC·Filed 2013·Application pending·0 cites
- 1658US11471430B2Sphingosine analogs and use thereof against bacterial lung infectionsYEDA RES & DEV·Filed 2019·Granted Oct 18, 2022·0 cites·9 claims
- 1758US2012283218A1MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDESYESAIR DAVID W·Filed 2012·Application pending·0 cites
- 1858US2017281775A1Modifications of solid 3-sn-phosphoglyceridesBIOMOLECULAR PRODUCTS INC·Filed 2016·Application pending·0 cites
- 1951US2016340298A1Novel compoundsAVANTI POLAR LIPIDS INC·Filed 2016·Application pending·0 cites
- 2045US2016024001A1Novel compoundsAVANTI POLAR LIPIDS INC·Filed 2014·Application pending·0 cites
- 2144US10739353B2Suppression of cytokine release and cytokine stormSIGNPATH PHARMA INC·Filed 2015·Granted Aug 11, 2020·0 cites·19 claims
- 2237US11413297B2Therapies for treating and preventing chronic rhinosinusitisAVANTI POLAR LIPIDS LLC·Filed 2018·Granted Aug 16, 2022·0 cites·28 claims
- 2335US2017349618A1Disaccharide synthetic lipid compounds and uses thereofAVANTI POLAR LIPIDS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen W. Burgess files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →